FIELD: medicine.
SUBSTANCE: method involves introducing biologically soluble ophthalmic medicine film impregnated with pyracin through a small incision in conjunctiva under Tennon's capsule. The film is pretreated with polymer composition for carrying out sclera-strengthening injections.
EFFECT: combined sclera-strengthening and stimulating action; prevented dystrophic changes in eye tunics.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CARRYING OUT MEDICAL TREATMENT OF PROGRESSIVE AND COMPLICATED MYOPIA | 2000 |
|
RU2192261C2 |
SCLERA-STRENGTHENING METHOD FOR TREATING THE CASES OF INFANTINE MYOPIA WITH HIGH RISK OF PROGRESSIVE DEVELOPMENT | 1999 |
|
RU2164111C2 |
REINFORCED TRANSPLANT FOR SCLEROPLASTIC OPERATIONS | 1998 |
|
RU2140242C1 |
DIAGNOSTIC TECHNIQUE FOR SCLERAL SUPPORT MALFUNCTION, ACCOMPANYING MYOPIA IN CHILDREN AND ADOLESCENTS | 2013 |
|
RU2541756C2 |
IMPLANT FOR OPERATIONS ON IMPROVING HUMAN EYE COVERS | 2014 |
|
RU2579281C1 |
TRANSPLANT FOR CARRYING OUT SCLEROPLASTIC RAPID PROGRESSING MYOPIA TREATMENT | 2005 |
|
RU2297811C1 |
METHOD OF COMBINED TREATMENT OF QUICKLY PROGRESSING MYOPIA IN CHILDREN | 2011 |
|
RU2454186C1 |
METHOD OF SURGICAL TREATMENT OF PROGRESSING AND COMPLICATED MYOPIA | 2012 |
|
RU2494711C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR EARLY ACQUIRED AND CONGENITAL PROGRESSIVE MYOPIA | 2012 |
|
RU2495420C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF KERATOCONUS AND CONGENITAL MYOPIA WITH HIGH REFRACTIVE POWER OF THE CORNEA AND ASTIGMATISM | 2021 |
|
RU2765438C1 |
Authors
Dates
2004-10-27—Published
2003-04-28—Filed